Mark Partin - Sep 27, 2024 Form 4 Insider Report for BLACKLINE, INC. (BL)

Signature
/s/ Karole Morgan-Prager, Attorney-in-Fact
Stock symbol
BL
Transactions as of
Sep 27, 2024
Transactions value $
-$220,272
Form type
4
Date filed
9/30/2024, 04:11 PM
Previous filing
Aug 22, 2024
Next filing
Oct 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BL Common Stock Options Exercise $42.5K +3.03K +1.34% $14.00 230K Sep 27, 2024 Direct F1
transaction BL Common Stock Sale -$161K -3.03K -1.32% $53.00 227K Sep 27, 2024 Direct F1
transaction BL Common Stock Options Exercise $36.6K +2.62K +1.15% $14.00 229K Sep 27, 2024 Direct F1
transaction BL Common Stock Sale -$139K -2.62K -1.14% $53.00 227K Sep 27, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BL Stock Option (Right to Buy) Options Exercise $0 -3.03K -7.11% $0.00 39.6K Sep 27, 2024 Common Stock 3.03K $14.00 Direct F1, F2
transaction BL Stock Option (Right to Buy) Options Exercise $0 -2.62K -5.42% $0.00 45.7K Sep 27, 2024 Common Stock 2.62K $14.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported on this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2024.
F2 The options became exercisable based on the following vesting schedule: The shares subject to the option vested in 4 equal, annual installments beginning on the one-year anniversary of the grant date, subject to the reporting person's continued service through each applicable vesting date.